{"entity":{"type":"insider","cik":"0001366268","url":"/insider/0001366268","json_url":"/insider/0001366268.json","name":"Kayyem Jon Faiz","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":131,"n_filings":83,"first":"2007-11-02","last":"2024-11-22","span_basis":"filed_date"},"name_variants":[{"name":"Kayyem Jon Faiz","source":"filing","n_filings":83,"first_seen":"2007-11-02","last_seen":"2024-11-22"}],"transactions":[{"id":2833750,"accession":"0002007919-24-000064","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0002007919-24-000064","line_url":"/filing/0002007919-24-000064#line-4","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx Biosciences, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18750.0,"shares_display":"18,750","price_per_share":14.1921,"price_display":"14.19","price_state":"stated","total_value":266101.875,"total_display":"266,101.88","shares_owned_after":69843.0,"shares_owned_after_display":"69,843","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-22","scope":"insider"},{"id":2833747,"accession":"0002007919-24-000064","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002007919-24-000064","line_url":"/filing/0002007919-24-000064#line-3","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx Biosciences, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18750.0,"shares_display":"18,750","price_per_share":14.1921,"price_display":"14.19","price_state":"stated","total_value":266101.875,"total_display":"266,101.88","shares_owned_after":69843.0,"shares_owned_after_display":"69,843","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-22","scope":"insider"},{"id":2833744,"accession":"0002007919-24-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002007919-24-000064","line_url":"/filing/0002007919-24-000064#line-2","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx Biosciences, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34843.0,"shares_display":"34,843","price_per_share":14.2269,"price_display":"14.23","price_state":"stated","total_value":495707.8767,"total_display":"495,707.88","shares_owned_after":51093.0,"shares_owned_after_display":"51,093","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-22","scope":"insider"},{"id":2833741,"accession":"0002007919-24-000064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002007919-24-000064","line_url":"/filing/0002007919-24-000064#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx Biosciences, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34843.0,"shares_display":"34,843","price_per_share":14.2269,"price_display":"14.23","price_state":"stated","total_value":495707.8767,"total_display":"495,707.88","shares_owned_after":51093.0,"shares_owned_after_display":"51,093","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-22","scope":"insider"},{"id":2575178,"accession":"0002007919-24-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002007919-24-000008","line_url":"/filing/0002007919-24-000008#line-2","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx Biosciences, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49284.0,"shares_display":"49,284","price_per_share":17.23,"price_display":"17.23","price_state":"stated","total_value":849163.32,"total_display":"849,163.32","shares_owned_after":1142145.0,"shares_owned_after_display":"1,142,145","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-05","filed_date":"2024-06-07","scope":"insider"},{"id":2575174,"accession":"0002007919-24-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002007919-24-000008","line_url":"/filing/0002007919-24-000008#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx Biosciences, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8265.0,"shares_display":"8,265","price_per_share":17.89,"price_display":"17.89","price_state":"stated","total_value":147860.85,"total_display":"147,860.85","shares_owned_after":1150410.0,"shares_owned_after_display":"1,150,410","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-05","filed_date":"2024-06-07","scope":"insider"},{"id":3103716,"accession":"0002007919-24-000006","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0002007919-24-000006","line_url":"/filing/0002007919-24-000006#line-5","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx Biosciences, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65337.0,"shares_display":"65,337","price_per_share":17.44,"price_display":"17.44","price_state":"stated","total_value":1139477.28,"total_display":"1,139,477.28","shares_owned_after":1069135.0,"shares_owned_after_display":"1,069,135","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-04","scope":"insider"},{"id":3103711,"accession":"0002007919-24-000006","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0002007919-24-000006","line_url":"/filing/0002007919-24-000006#line-4","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx Biosciences, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23726.0,"shares_display":"23,726","price_per_share":18.24,"price_display":"18.24","price_state":"stated","total_value":432762.24,"total_display":"432,762.24","shares_owned_after":1092861.0,"shares_owned_after_display":"1,092,861","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-04","scope":"insider"},{"id":3103707,"accession":"0002007919-24-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002007919-24-000006","line_url":"/filing/0002007919-24-000006#line-3","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx Biosciences, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80738.0,"shares_display":"80,738","price_per_share":17.9,"price_display":"17.90","price_state":"stated","total_value":1445210.2,"total_display":"1,445,210.20","shares_owned_after":1003798.0,"shares_owned_after_display":"1,003,798","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-04","scope":"insider"},{"id":3103702,"accession":"0002007919-24-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002007919-24-000006","line_url":"/filing/0002007919-24-000006#line-2","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx Biosciences, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":46792.0,"shares_display":"46,792","price_per_share":16.61,"price_display":"16.61","price_state":"stated","total_value":777215.12,"total_display":"777,215.12","shares_owned_after":923060.0,"shares_owned_after_display":"923,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-04","scope":"insider"},{"id":3103696,"accession":"0002007919-24-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002007919-24-000006","line_url":"/filing/0002007919-24-000006#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx Biosciences, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70193.0,"shares_display":"70,193","price_per_share":16.14,"price_display":"16.14","price_state":"stated","total_value":1132915.02,"total_display":"1,132,915.02","shares_owned_after":876268.0,"shares_owned_after_display":"876,268","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-06-04","scope":"insider"},{"id":8049456,"accession":"0001739614-23-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-23-000008","line_url":"/filing/0001739614-23-000008#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9500.0,"shares_display":"9,500","price_per_share":25.2631,"price_display":"25.26","price_state":"stated","total_value":239999.45,"total_display":"239,999.45","shares_owned_after":3224301.0,"shares_owned_after_display":"3,224,301","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-23","scope":"insider"},{"id":6291857,"accession":"0001739614-22-000132","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001739614-22-000132","line_url":"/filing/0001739614-22-000132#line-2","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7541.0,"shares_display":"7,541","price_per_share":26.8653,"price_display":"26.87","price_state":"stated","total_value":202591.2273,"total_display":"202,591.23","shares_owned_after":3235760.0,"shares_owned_after_display":"3,235,760","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-22","scope":"insider"},{"id":6291854,"accession":"0001739614-22-000132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-22-000132","line_url":"/filing/0001739614-22-000132#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1959.0,"shares_display":"1,959","price_per_share":27.6099,"price_display":"27.61","price_state":"stated","total_value":54087.7941,"total_display":"54,087.79","shares_owned_after":3233801.0,"shares_owned_after_display":"3,233,801","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-22","scope":"insider"},{"id":6887655,"accession":"0001140361-22-042596","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-042596","line_url":"/filing/0001140361-22-042596#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"BIODESIX INC","issuer_ticker":"BDSX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":173913.0,"shares_display":"173,913","price_per_share":1.15,"price_display":"1.15","price_state":"stated","total_value":199999.95,"total_display":"199,999.95","shares_owned_after":173913.0,"shares_owned_after_display":"173,913","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-21","scope":"insider"},{"id":6231099,"accession":"0001739614-22-000126","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001739614-22-000126","line_url":"/filing/0001739614-22-000126#line-2","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6767.0,"shares_display":"6,767","price_per_share":30.1196,"price_display":"30.12","price_state":"stated","total_value":203819.3332,"total_display":"203,819.33","shares_owned_after":3243301.0,"shares_owned_after_display":"3,243,301","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-22","scope":"insider"},{"id":6231090,"accession":"0001739614-22-000126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-22-000126","line_url":"/filing/0001739614-22-000126#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2733.0,"shares_display":"2,733","price_per_share":29.3279,"price_display":"29.33","price_state":"stated","total_value":80153.1507,"total_display":"80,153.15","shares_owned_after":3250068.0,"shares_owned_after_display":"3,250,068","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-22","scope":"insider"},{"id":6231087,"accession":"0001739614-22-000109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001739614-22-000109","line_url":"/filing/0001739614-22-000109#line-2","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5928.0,"shares_display":"5,928","price_per_share":30.576,"price_display":"30.58","price_state":"stated","total_value":181254.528,"total_display":"181,254.53","shares_owned_after":3252801.0,"shares_owned_after_display":"3,252,801","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-21","filed_date":"2022-10-24","scope":"insider"},{"id":6231076,"accession":"0001739614-22-000109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001739614-22-000109","line_url":"/filing/0001739614-22-000109#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"Inhibrx, Inc.","issuer_ticker":"INBX","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3572.0,"shares_display":"3,572","price_per_share":29.3889,"price_display":"29.39","price_state":"stated","total_value":104977.1508,"total_display":"104,977.15","shares_owned_after":3258729.0,"shares_owned_after_display":"3,258,729","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-21","filed_date":"2022-10-24","scope":"insider"},{"id":6244267,"accession":"0001487371-18-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-18-000017","line_url":"/filing/0001487371-18-000017#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":148.0,"shares_display":"148","price_per_share":5.13,"price_display":"5.13","price_state":"stated","total_value":759.24,"total_display":"759.24","shares_owned_after":197622.0,"shares_owned_after_display":"197,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-02","filed_date":"2018-02-06","scope":"insider"},{"id":5192073,"accession":"0001487371-17-000251","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-17-000251","line_url":"/filing/0001487371-17-000251#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135.0,"shares_display":"135","price_per_share":4.7,"price_display":"4.70","price_state":"stated","total_value":634.5,"total_display":"634.50","shares_owned_after":197770.0,"shares_owned_after_display":"197,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-04","filed_date":"2017-12-06","scope":"insider"},{"id":5368305,"accession":"0001487371-17-000240","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-17-000240","line_url":"/filing/0001487371-17-000240#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1269.0,"shares_display":"1,269","price_per_share":4.74,"price_display":"4.74","price_state":"stated","total_value":6015.06,"total_display":"6,015.06","shares_owned_after":197905.0,"shares_owned_after_display":"197,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-20","filed_date":"2017-11-21","scope":"insider"},{"id":5090127,"accession":"0001487371-17-000227","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-17-000227","line_url":"/filing/0001487371-17-000227#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135.0,"shares_display":"135","price_per_share":7.24,"price_display":"7.24","price_state":"stated","total_value":977.4,"total_display":"977.40","shares_owned_after":199174.0,"shares_owned_after_display":"199,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-02","filed_date":"2017-11-03","scope":"insider"},{"id":4851426,"accession":"0001487371-17-000190","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-17-000190","line_url":"/filing/0001487371-17-000190#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":133.0,"shares_display":"133","price_per_share":9.75,"price_display":"9.75","price_state":"stated","total_value":1296.75,"total_display":"1,296.75","shares_owned_after":199309.0,"shares_owned_after_display":"199,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-05","filed_date":"2017-09-06","scope":"insider"},{"id":4177385,"accession":"0001487371-17-000181","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-17-000181","line_url":"/filing/0001487371-17-000181#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1277.0,"shares_display":"1,277","price_per_share":9.45,"price_display":"9.45","price_state":"stated","total_value":12067.65,"total_display":"12,067.65","shares_owned_after":199442.0,"shares_owned_after_display":"199,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-21","filed_date":"2017-08-23","scope":"insider"},{"id":4763934,"accession":"0001487371-17-000164","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-17-000164","line_url":"/filing/0001487371-17-000164#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":138.0,"shares_display":"138","price_per_share":10.33,"price_display":"10.33","price_state":"stated","total_value":1425.54,"total_display":"1,425.54","shares_owned_after":200719.0,"shares_owned_after_display":"200,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-02","filed_date":"2017-08-04","scope":"insider"},{"id":4476822,"accession":"0001487371-17-000138","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-17-000138","line_url":"/filing/0001487371-17-000138#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":132.0,"shares_display":"132","price_per_share":12.89,"price_display":"12.89","price_state":"stated","total_value":1701.48,"total_display":"1,701.48","shares_owned_after":200857.0,"shares_owned_after_display":"200,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-02","filed_date":"2017-06-05","scope":"insider"},{"id":4131574,"accession":"0001487371-17-000115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-17-000115","line_url":"/filing/0001487371-17-000115#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1265.0,"shares_display":"1,265","price_per_share":12.89,"price_display":"12.89","price_state":"stated","total_value":16305.85,"total_display":"16,305.85","shares_owned_after":200989.0,"shares_owned_after_display":"200,989","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-19","filed_date":"2017-05-23","scope":"insider"},{"id":5228699,"accession":"0001487371-17-000100","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-17-000100","line_url":"/filing/0001487371-17-000100#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":133.0,"shares_display":"133","price_per_share":13.34,"price_display":"13.34","price_state":"stated","total_value":1774.22,"total_display":"1,774.22","shares_owned_after":202254.0,"shares_owned_after_display":"202,254","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-02","filed_date":"2017-05-04","scope":"insider"},{"id":4586233,"accession":"0001487371-17-000074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-17-000074","line_url":"/filing/0001487371-17-000074#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":311.0,"shares_display":"311","price_per_share":12.18,"price_display":"12.18","price_state":"stated","total_value":3787.98,"total_display":"3,787.98","shares_owned_after":202387.0,"shares_owned_after_display":"202,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-07","filed_date":"2017-03-09","scope":"insider"},{"id":5368296,"accession":"0001487371-17-000070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-17-000070","line_url":"/filing/0001487371-17-000070#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":131.0,"shares_display":"131","price_per_share":12.29,"price_display":"12.29","price_state":"stated","total_value":1609.99,"total_display":"1,609.99","shares_owned_after":202698.0,"shares_owned_after_display":"202,698","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-03","filed_date":"2017-03-03","scope":"insider"},{"id":5004233,"accession":"0001487371-17-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-17-000040","line_url":"/filing/0001487371-17-000040#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5250.0,"shares_display":"5,250","price_per_share":10.08,"price_display":"10.08","price_state":"stated","total_value":52920.0,"total_display":"52,920.00","shares_owned_after":154079.0,"shares_owned_after_display":"154,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-21","filed_date":"2017-02-21","scope":"insider"},{"id":4962618,"accession":"0001487371-17-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-17-000022","line_url":"/filing/0001487371-17-000022#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":131.0,"shares_display":"131","price_per_share":11.58,"price_display":"11.58","price_state":"stated","total_value":1516.98,"total_display":"1,516.98","shares_owned_after":159329.0,"shares_owned_after_display":"159,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-02","filed_date":"2017-02-03","scope":"insider"},{"id":4317000,"accession":"0001487371-17-000013","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001487371-17-000013","line_url":"/filing/0001487371-17-000013#line-3","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5718.0,"shares_display":"5,718","price_per_share":12.47,"price_display":"12.47","price_state":"stated","total_value":71303.46,"total_display":"71,303.46","shares_owned_after":159460.0,"shares_owned_after_display":"159,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-19","filed_date":"2017-01-20","scope":"insider"},{"id":3130368,"accession":"0001487371-16-000398","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-16-000398","line_url":"/filing/0001487371-16-000398#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":313.0,"shares_display":"313","price_per_share":11.08,"price_display":"11.08","price_state":"stated","total_value":3468.04,"total_display":"3,468.04","shares_owned_after":151547.0,"shares_owned_after_display":"151,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-07","filed_date":"2016-12-09","scope":"insider"},{"id":2340268,"accession":"0001487371-16-000392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-16-000392","line_url":"/filing/0001487371-16-000392#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":132.0,"shares_display":"132","price_per_share":11.3,"price_display":"11.30","price_state":"stated","total_value":1491.6,"total_display":"1,491.60","shares_owned_after":151860.0,"shares_owned_after_display":"151,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-02","filed_date":"2016-12-06","scope":"insider"},{"id":2855740,"accession":"0001487371-16-000376","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-16-000376","line_url":"/filing/0001487371-16-000376#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135.0,"shares_display":"135","price_per_share":10.3,"price_display":"10.30","price_state":"stated","total_value":1390.5,"total_display":"1,390.50","shares_owned_after":151992.0,"shares_owned_after_display":"151,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-02","filed_date":"2016-11-04","scope":"insider"},{"id":3345710,"accession":"0001487371-16-000357","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-16-000357","line_url":"/filing/0001487371-16-000357#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":310.0,"shares_display":"310","price_per_share":8.69,"price_display":"8.69","price_state":"stated","total_value":2693.9,"total_display":"2,693.90","shares_owned_after":152127.0,"shares_owned_after_display":"152,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-07","filed_date":"2016-09-09","scope":"insider"},{"id":3191661,"accession":"0001487371-16-000347","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-16-000347","line_url":"/filing/0001487371-16-000347#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":133.0,"shares_display":"133","price_per_share":8.62,"price_display":"8.62","price_state":"stated","total_value":1146.46,"total_display":"1,146.46","shares_owned_after":152437.0,"shares_owned_after_display":"152,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-02","filed_date":"2016-09-06","scope":"insider"},{"id":2718389,"accession":"0001487371-16-000329","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-16-000329","line_url":"/filing/0001487371-16-000329#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135.0,"shares_display":"135","price_per_share":9.88,"price_display":"9.88","price_state":"stated","total_value":1333.8,"total_display":"1,333.80","shares_owned_after":152570.0,"shares_owned_after_display":"152,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-02","filed_date":"2016-08-04","scope":"insider"},{"id":2615285,"accession":"0001487371-16-000312","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001487371-16-000312","line_url":"/filing/0001487371-16-000312#line-2","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":310.0,"shares_display":"310","price_per_share":8.98,"price_display":"8.98","price_state":"stated","total_value":2783.8,"total_display":"2,783.80","shares_owned_after":152705.0,"shares_owned_after_display":"152,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-07","scope":"insider"},{"id":2615281,"accession":"0001487371-16-000312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-16-000312","line_url":"/filing/0001487371-16-000312#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125.0,"shares_display":"125","price_per_share":8.53,"price_display":"8.53","price_state":"stated","total_value":1066.25,"total_display":"1,066.25","shares_owned_after":153015.0,"shares_owned_after_display":"153,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-03","filed_date":"2016-06-07","scope":"insider"},{"id":3232306,"accession":"0001487371-16-000283","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-16-000283","line_url":"/filing/0001487371-16-000283#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135.0,"shares_display":"135","price_per_share":5.79,"price_display":"5.79","price_state":"stated","total_value":781.65,"total_display":"781.65","shares_owned_after":153140.0,"shares_owned_after_display":"153,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-02","filed_date":"2016-05-04","scope":"insider"},{"id":2570874,"accession":"0001487371-16-000252","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-16-000252","line_url":"/filing/0001487371-16-000252#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":364.0,"shares_display":"364","price_per_share":5.76,"price_display":"5.76","price_state":"stated","total_value":2096.64,"total_display":"2,096.64","shares_owned_after":153275.0,"shares_owned_after_display":"153,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-07","filed_date":"2016-03-09","scope":"insider"},{"id":2918855,"accession":"0001487371-16-000245","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001487371-16-000245","line_url":"/filing/0001487371-16-000245#line-2","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":157.0,"shares_display":"157","price_per_share":4.87,"price_display":"4.87","price_state":"stated","total_value":764.59,"total_display":"764.59","shares_owned_after":153639.0,"shares_owned_after_display":"153,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-02","filed_date":"2016-03-03","scope":"insider"},{"id":2918851,"accession":"0001487371-16-000245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-16-000245","line_url":"/filing/0001487371-16-000245#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1385.0,"shares_display":"1,385","price_per_share":4.93,"price_display":"4.93","price_state":"stated","total_value":6828.05,"total_display":"6,828.05","shares_owned_after":153796.0,"shares_owned_after_display":"153,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-01","filed_date":"2016-03-03","scope":"insider"},{"id":2718383,"accession":"0001487371-16-000207","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-16-000207","line_url":"/filing/0001487371-16-000207#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1916.0,"shares_display":"1,916","price_per_share":4.99,"price_display":"4.99","price_state":"stated","total_value":9560.84,"total_display":"9,560.84","shares_owned_after":101894.0,"shares_owned_after_display":"101,894","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-03","filed_date":"2016-02-05","scope":"insider"},{"id":2340250,"accession":"0001487371-16-000189","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001487371-16-000189","line_url":"/filing/0001487371-16-000189#line-2","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78.0,"shares_display":"78","price_per_share":6.8,"price_display":"6.80","price_state":"stated","total_value":530.4,"total_display":"530.40","shares_owned_after":103810.0,"shares_owned_after_display":"103,810","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-21","filed_date":"2016-01-25","scope":"insider"},{"id":8430315,"accession":"0001487371-15-000181","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001487371-15-000181","line_url":"/filing/0001487371-15-000181#line-1","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":328.0,"shares_display":"328","price_per_share":7.26,"price_display":"7.26","price_state":"stated","total_value":2381.28,"total_display":"2,381.28","shares_owned_after":103719.0,"shares_owned_after_display":"103,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-08","filed_date":"2015-12-10","scope":"insider"},{"id":8805019,"accession":"0001487371-15-000174","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001487371-15-000174","line_url":"/filing/0001487371-15-000174#line-2","is_derivative":false,"issuer_cik":"0001366268","issuer_name":"GenMark Diagnostics, Inc.","issuer_ticker":"GNMK","issuer_name_source":null,"issuer_url":"/issuer/0001366268","owner_cik":"0001366268","owner_name":"Kayyem Jon Faiz","owner_url":"/insider/0001366268","role":"Officer (SVP, Research & Development)","officer_title":"SVP, Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":132.0,"shares_display":"132","price_per_share":7.71,"price_display":"7.71","price_state":"stated","total_value":1017.72,"total_display":"1,017.72","shares_owned_after":104047.0,"shares_owned_after_display":"104,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-03","filed_date":"2015-12-04","scope":"insider"}],"next_cursor":"2015-12-03|8805019","ledger_fault":false,"count":{"value":87,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":15,"open_market":true},{"code":"S","label":"Open-market sale","n":72,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":87},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002007919","name":"Inhibrx Biosciences, Inc.","url":"/issuer/0002007919","role":"Director","n_filings":3,"first_seen":"2024-06-04","last_seen":"2024-11-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001739614","name":"Inhibrx, Inc.","url":"/issuer/0001739614","role":"Director","n_filings":4,"first_seen":"2022-10-24","last_seen":"2023-01-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001439725","name":"BIODESIX INC","url":"/issuer/0001439725","role":"Director","n_filings":1,"first_seen":"2022-11-21","last_seen":"2022-11-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001487371","name":"GenMark Diagnostics, Inc.","url":"/issuer/0001487371","role":"Director, Officer (SVP, Research & Development)","n_filings":57,"first_seen":"2010-06-07","last_seen":"2018-02-06"},{"type":"issuer","type_label":"ISSUER","cik":"0000897075","name":"REPROS THERAPEUTICS INC.","url":"/issuer/0000897075","role":"Ten percent owner","n_filings":18,"first_seen":"2007-11-02","last_seen":"2008-11-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001366268","retrieved_at":"2026-08-21T13:50:49+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}